Related Experiment Video
Updated: Aug 14, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
New insights into the pathophysiology, classification, and diagnosis of coronary microvascular dysfunction
1Division of Cardiology, School of Medicine, University of New Mexico, Albuquerque, New Mexico, USA.
Insights
Coronary microvascular dysfunction (CMVD) predicts poor outcomes in heart disease patients. Despite its prevalence, effective targeted therapies for CMVD are lacking, necessitating further research.
Area of Science:
- Cardiology
- Vascular Biology
- Diagnostic Imaging
Background:
- The coronary microvasculature is crucial for regulating coronary blood flow and myocardial oxygen supply.
- Coronary microvascular dysfunction (CMVD) is increasingly recognized as an independent predictor of adverse cardiovascular outcomes.
- Understanding CMVD is challenging due to the complexity of microvascular anatomy and functional pathways.
Purpose of the Study:
- To review the current understanding of coronary microvascular dysfunction (CMVD).
- To discuss the diagnostic challenges and limitations of current assessment tools for CMVD.
- To highlight the clinical significance and unmet therapeutic needs in managing CMVD.
Main Methods:
- Review of existing literature on coronary microvasculature and CMVD.
- Discussion of invasive and noninvasive diagnostic modalities for assessing CMVD.
- Analysis of current clinical classifications and treatment recommendations for CMVD.
Main Results:
- CMVD is prevalent across various cardiac conditions, with or without epicardial coronary artery disease.
- Invasive assessment of coronary blood flow and microvascular resistance remains the gold standard.
- Despite recognized poor outcomes, targeted therapies for CMVD are currently unavailable.
Conclusions:
- CMVD is a significant clinical entity associated with poor prognosis in cardiovascular disease.
- Current management focuses on symptom relief and risk factor modification due to a lack of specific therapies.
- There is a critical need for robust clinical trials to evaluate targeted treatment strategies for CMVD.
Abstract:
The coronary microvasculature plays a key role in determining and modulating coronary blood flow across the spectrum of myocardial demand. Our understanding of this complex system has been limited partly due to our inability to visualize the anatomy of an extensive microvascular bed and its complicated functional pathways. Nonetheless, research has led to the current belief that coronary microvascular dysfunction (CMVD) is a clinical entity that is an independent predictor of poor long-term outcomes in patients across a broad spectrum of cardiac diseases. CMVD exists in many clinical forms, in the presence and absence of epicardial coronary artery disease and structural heart disease. Both invasive and noninvasive tools have been used to assess the functional aspects of CMVD and both come with limitations. To date, invasive testing to assess coronary blood flow and microvascular resistance in response to provocative and hyperemic stimuli remains the gold standard. A recent clinical classification has been put forth to correctly categorize patients with CMVD. Despite the adverse outcomes associated with CMVD, proven targeted therapies remain elusive. Symptom relief and cardiovascular risk factor modification are the goals of current recommendations. There is a strong need for adequately powered trials to test specific management strategies and their effect on outcomes among patients with CMVD.
More Related Videos
08:35Oxygenation-sensitive Cardiac MRI with Vasoactive Breathing Maneuvers for the Non-invasive Assessment of Coronary Microvascular Dysfunction
Published on: August 17, 2022
08:21Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations
Published on: July 21, 2023
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease III: Clinical Manifestations
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation